MARKET

OSUR

OSUR

Orasure Tech
NASDAQ
3.790
-0.110
-2.82%
After Hours: 3.790 0 -0.01% 16:07 09/30 EDT
OPEN
3.830
PREV CLOSE
3.900
HIGH
3.980
LOW
3.770
VOLUME
1.31M
TURNOVER
0
52 WEEK HIGH
11.89
52 WEEK LOW
2.620
MARKET CAP
275.23M
P/E (TTM)
-4.2647
1D
5D
1M
3M
1Y
5Y
Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Simply Wall St. · 15h ago
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
Benzinga · 3d ago
OraSure wins $8.6M government contract for next-gen Ebola test
OraSure Technologies, Inc. (NASDAQ:OSUR), a developer ...
Seekingalpha · 3d ago
BRIEF-OraSure Technologies Receives $8.6 Million BARDA Contract To Develop 2nd Generation Ebola Test
BRIEF-OraSure Technologies Receives $8.6 Million BARDA Contract To Develop 2nd Generation Ebola Test
Reuters · 3d ago
OraSure Technologies Received $8.6M BARDA Contract to Develop 2nd Generation Ebola Test
OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the Biomedical Advanced Research and Development Authority (BARDA) has issued the Company an $8.6 million contract to develop a 2nd generation Ebola test on the OraQuick® testing platform.
Benzinga · 3d ago
OraSure Technologies Wins $8.6 Million BARDA Contract to Develop Second-Generation Ebola Test
OraSure Technologies Wins $8.6 Million BARDA Contract to Develop Second-Generation Ebola Test
MT Newswires · 3d ago
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Benzinga · 4d ago
FDA updates COVID-19 test policy to cut emergency use requests
Revising its COVID-19 test policy, the U.S. Food and Drug Administration (FDA) said Tuesday that the agency would review only a small number of new emergency use authorization (EUA) requests for diagnostic tests.Instead, the FDA urges deve...
Seekingalpha · 4d ago
More
About OSUR
OraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's segments consist of Diagnostics and Molecular Solutions. Diagnostics business segment primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products. The Diagnostics business includes tests for diseases including COVID-19, human immunodeficiency virus (HIV) and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Molecular Solutions business products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Webull offers kinds of OraSure Technologies, Inc. stock information, including NASDAQ:OSUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSUR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OSUR stock methods without spending real money on the virtual paper trading platform.